Validity of positron emission tomography using fluoro-2-deoxyglucose for the preoperative evaluation of endometrial cancer
- 13 July 2007
- journal article
- clinical trial
- Published by BMJ in International Journal of Gynecologic Cancer
- Vol. 17 (4), 890-896
- https://doi.org/10.1111/j.1525-1438.2007.00859.x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Positron emission tomography application for gynecologic tumorsInternational Journal of Gynecologic Cancer, 2005
- PET imaging in gynecologic malignanciesRadiologic Clinics of North America, 2004
- Value of 18F-FDG PET in the detection of peritoneal carcinomatosisEuropean Journal of Nuclear Medicine and Molecular Imaging, 2004
- Usefulness of 18F-FDG PET in the post-therapy surveillance of endometrial carcinomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2002
- Positron Emission Tomography/Computed Tomography Imaging for the Detection of Recurrent Ovarian and Fallopian Tube Carcinoma: A Retrospective ReviewGynecologic Oncology, 2002
- Prognostic Value of Positron Emission Tomography Using F-18-Fluorodeoxyglucose in Patients with Cervical Cancer Undergoing RadiotherapyGynecologic Oncology, 2002
- 2-[Fluorine-18]-fluoro-2-deoxy-
d -glucose Positron Emission Tomography in the Diagnosis of Recurrent Ovarian CancerGynecologic Oncology, 2001 - Positive Emission Tomography for Evaluating a Complete Clinical Response in Patients with Ovarian or Peritoneal Carcinoma: Correlation with Second-Look LaparotomyGynecologic Oncology, 2001
- Positron Emission Tomography with 18F-Fluorodeoxyglucose of Uterine Sarcoma: A Comparison with Magnetic Resonance Imaging and Power Doppler ImagingGynecologic Oncology, 2001
- Metastatic Lymph Nodes in Patients with Cervical Cancer: Detection with MR Imaging and FDG PETRadiology, 2001